| Location: | Federal |
|---|---|
| Posted: | Dec 1, 2025 |
| Due: | Jan 22, 2026 |
| Agency: | Government of Canada |
| Type of Government: | State & Local |
| Category: |
|
| Solicitation No: | W6369-26-A033 |
| Publication URL: | To access bid details, please log in. |
Description
The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to chemical warfare agents.
The initial requirement is for the delivery of 1,025 doses to be delivered before 31 March 2026. Optional requirements of 4,100 doses to be requested and delivered between 01 April 2026 and 31 March 2030.
There are no security requirements associated with this requirement.
The Crown retains the rights to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreement(s)): and to Suppliers of an applicable trading partner.
The estimated contract period will be 49 month(s), with a proposed start date of 2026/02/18.
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
Are you interested in partnering with other businesses for this opportunity? Add your company to the list of businesses who are interested in partnering .
This list does not replace or affect the tendering procedures for this procurement process. Businesses are still required to respond to bid solicitations, and to compete based on the set criteria. For more information please read the Terms of use .

With GovernmentContracts, you can: